B-Complex Vitamin Injection Vials Recalled for Particulate Matter
AnazaoHealth is recalling B-Complex injection vials due to particulate matter contamination. Affected patients should discontinue use and consult their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a risk-of-harm product (particulate matter in injectable medication). No illnesses or injuries have been reported in the source. Per the severity rubric, Class II recalls without reported hospitalization that present risk of harm are classified as High (score 3).
Plain-English summary
AnazaoHealth Corporation is recalling B-Complex vitamin injection vials nationwide due to the presence of particulate matter, which compromises the sterility required for injectable products.
The recall affects 5,707 vials distributed across the United States under NDC 72682-2230-3. Multiple lot numbers are affected, with expiration dates from February 2024 through March 2024.
Healthcare providers should immediately stop using affected vials. Patients who have received injections from recalled lots should contact their healthcare provider for appropriate guidance.
The recalled product
- Product
- B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3
- Manufacturer
- AnazaoHealth Corporation
- Category
- Drug — Vitamin Injection
- Hazard
- particulate-matter
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: 505075
- Exp: 02/05/24
- 505596
- Exp: 02/06/24
- 506155
- Exp: 02/07/24
- 508103
- Exp: 02/13/24
- 510837
- Exp: 02/19/24
- 512411
- Exp: 02/20/24
- 514856
- Exp: 02/25/24
- 515642
- Exp: 02/28/24
- 518309
- Exp: 03/05/24
- 524262
- 524266
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01